SCHEMBL21363954

SCHEMBL21363954

Cc1cccc(C)c1-c1cncc(-c2c3ccccc3c(-c3cncc(-c4c(C)cccc4C)c3)c3ccccc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.39
CYP1A2 P05177 3/20 0.39
ALDH1A1 P00352 2/20 0.39
SRC P12931 3/20 0.37
KDM4E B2RXH2 3/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
BACE1 P56817 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
GRIA1 P42261 1/20 0.35
CACNG8 Q8WXS5 1/20 0.35
BRD4 O60885 1/20 0.35
ADORA2A P29274 1/20 0.34
HTR7 P34969 1/20 0.34
YES1 P07947 1/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21363961 0.87 GABRA1 (0.38) CYP2A6CYP1A2ALDH1A1SRCKDM4E
SCHEMBL21363958 0.87 LMNA (0.39) CYP2A6CYP1A2ALDH1A1LMNAHTR7
SCHEMBL21364025 0.86 S1PR4 (0.36) CYP2A6CYP1A2ALDH1A1KDM4ELMNA
SCHEMBL21363955 0.85 NOS3 (0.37) CYP2A6CYP1A2ALDH1A1KDM4ELMNA
SCHEMBL21364096 0.85 ALOX5AP (0.41) CYP2A6CYP1A2ALDH1A1KDM4ELMNA
SCHEMBL21476134 0.80 CYP2A6 (0.50) CYP2A6SRCBACE1GRIA1CACNG8
SCHEMBL3365805 0.78 MEN1 (0.44) CYP2A6SRCMKNK1MKNK2
SCHEMBL12345157 0.78 MKNK1 (0.50) ALDH1A1MKNK1MKNK2
SCHEMBL15161100 0.77 CYP2A6 (0.45) CYP2A6BACE1MKNK1MKNK2KMT2A
SCHEMBL19970452 0.74 KDM4E (0.43) CYP1A2ALDH1A1KDM4ELMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145821-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2021-10-12 US disclosed
US-20190288216-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145821-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device LEF1, SLC25A21, EMC2 CYP2A6 2693/4885CYP1A2 317/4885ALDH1A1 515/4885
US-20190288216-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE LEF1, SLC25A21, EMC2 CYP2A6 2693/4885CYP1A2 317/4885ALDH1A1 515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.